Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge
Viatris Inc (NASDAQ:VTRS) has agreed to acquire Oyster Point Pharma Inc (NASDAQ:OYST) as the foundation of its new ophthalmology franchise. Viatris will…
Why Viatris Shares Are Soaring Higher
Viatris Inc (NASDAQ: VTRS) shares are trading higher by 16.80% to $11.33 Monday morning after the company announced it will acquire Oyster Point Pharma.
What Happened?
Recap: Viatris Q3 Earnings
Viatris (NASDAQ:VTRS) reported its Q3 earnings results on Monday, November 7, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
Viatris beat estimated earnings by 3.57%, reporting an EPS of $0.87 versus an estimate of $0.84.
US Stocks Show Optimism Heading Into Midterms Week As Nasdaq, S&P 500 Futures Rally — Apple, Meta, Palantir In Focus Today
U.S. index futures were all in the green on Monday morning, indicating that Wall Street may start the week on a moderately positive note.
Monday’s economic calendar is light and doesn’t boast of any major market-moving data or reports. Traders could show apprehension ahead of the Nov. 8 midterm elections and the consumer price inflation report due on Thursday.
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell
• NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
How To Attend Viatris Q3 2022 Earnings Conference Call
Viatris (NASDAQ:VTRS) will host a conference call at 08:30 AM ET on November 7, 2022, to discuss Q3 2022 earnings results.
How to Attend Viatris (VTRS) Conference Call
Follow this link to access the live webcast.
Viatris’ Mylan Recalls One Lot Of Octreotide Acetate Injection Due To Glass Particulates
Viatris Inc’s (NASDAQ:VTRS) Mylan is voluntarily recalling one lot of Octreotide Acetate Injection, 500 mcg/mL, packaged in a carton of ten 1mL syringes…
